Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phase 1, pharmacogenomic, dose-expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1-deficient non-squamous non-small cell lung cancer. | Cancer Med | 2021 | 34382365 | PubTator, text mining | PubMed |
| PGC1α is required for the renoprotective effect of lncRNA Tug1 in vivo and links Tug1 with urea cycle metabolites. | Cell Rep | 2021 | 34380028 | PubTator, text mining | PubMed |
| Synergistic Neuroprotective Effects of a Natural Product Mixture against AD Hallmarks and Cognitive Decline in Caenorhabditis elegans and an SAMP8 Mice Model. | Nutrients | 2021 | 34371921 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma. | Front Oncol | 2021 | 34367994 | PubTator, text mining | PubMed |
| Differences in Alzheimer's Disease and Related Dementias Pathology Among African American and Hispanic Women: A Qualitative Literature Review of Biomarker Studies. | Front Syst Neurosci | 2021 | 34366799 | PubTator, text mining | PubMed |
| In Silico Multi-Compartment Detection Based on Multiplex Immunohistochemical Staining in Renal Pathology. | Proc SPIE Int Soc Opt Eng | 2021 | 34366541 | PubTator, text mining | PubMed |
| Comparative Genomics of Clinical Isolates of the Emerging Tick-Borne Pathogen Neoehrlichia mikurensis. | Microorganisms | 2021 | 34361922 | PubTator, text mining | PubMed |
| Phytochemicals in Malignant Pleural Mesothelioma Treatment-Review on the Current Trends of Therapies. | Int J Mol Sci | 2021 | 34361048 | PubTator, text mining | PubMed |
| Effects of Dihydrotanshinone I on Proliferation and Invasiveness of Paclitaxel-Resistant Anaplastic Thyroid Cancer Cells. | Int J Mol Sci | 2021 | 34360846 | PubTator, text mining | PubMed |
| Interactions Networks for Primary Heart Sarcomas. | Cancers (Basel) | 2021 | 34359782 | PubTator, text mining | PubMed |
| Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies. | Neurochem Res | 2021 | 34357520 | PubTator, text mining | PubMed |
| The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer. | Cancer Metab | 2021 | 34344457 | PubTator, text mining | PubMed |
| Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach. | Microb Pathog | 2021 | 34333072 | PubTator, text mining | PubMed |
| p53 induces a survival transcriptional response after nucleolar stress. | Mol Biol Cell | 2021 | 34319761 | PubTator, text mining | PubMed |
| On the prevention and treatment of Alzheimer's disease: Control the promoters and look beyond the brain. | Med Hypotheses | 2021 | 34315048 | PubTator, text mining | PubMed |
| Assessment of SENP3-interacting proteins in hepatocytes treated with diethylnitrosamine by BioID assay. | Acta Biochim Biophys Sin (Shanghai) | 2021 | 34312671 | PubTator, text mining | PubMed |
| Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment. | Cancer Chemother Pharmacol | 2021 | 34309734 | PubTator, text mining | PubMed |
| The Regulation Network and Clinical Significance of Circular RNAs in Breast Cancer. | Front Oncol | 2021 | 34307155 | PubTator, text mining | PubMed |
| Enhancing the Effect of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Signaling and Arginine Deprivation in Melanoma. | Int J Mol Sci | 2021 | 34299249 | PubTator, text mining | PubMed |
| Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration. | Int J Mol Sci | 2021 | 34298999 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=53